News

The 2026 FOP Community Holiday Gift Guide

Read more Share

Mirum Announces 24-Week Results from Cohort 2 in the PROGRESS Clinical Trial

Read more Share

Mindfulness for the FOP Community: A New Resilient Living Program

Read more Share

How Does a Drug Get Its Name?

Read more Share

Your Next Donation Idea Might Be Sitting in a Friend’s Driveway

Read more Share

ãshibio Shares Preliminary Efficacy Data from the ANDECAL Clinical Trial at ASBMR 2026 Annual Meeting

Read more Share

Regeneron Shares 84-Week Results from the OPTIMA Trial at ASBMR 2026 Annual Meeting

Read more Share

Regeneron's OPTIMA Trial Results Published in The Lancet

Read more Share

U.S. FDA Approves Mirum Pharmaceuticals' Zilurgisertib as a Treatment for FOP

Read more Share

A Mouse Model Moving FOP Research Forward

Read more Share

Make a Difference

Donate Connect Fundraise
Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter

X